Table 3 Concentration and frequency of β-thymosins in scleroderma patients with or without alveolitis
From: β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up
24 scleroderma pts with alveolitis | 22 scleroderma pts without alveolitis | |
|---|---|---|
presence of Tβ4, n pts (%) | 24 (100%) | 22 (100%) |
Tβ4 (μmol/L, mean ± SD) | 0.356 ± 0.464 | 0.256 ± 0.236 |
(median, range) | (0.21, 0-2.1) | (0.13, 0-1.0) |
presence of sTβ4, n pts (%) | 10 (41.6%) | 4 (18.1%) |
sTβ4 (μmol/L, mean ± SD) | 0.025 ± 0.052* | 0.006 ± 0.219 |
(median, range) | (0, 0-0.24) | (0, 0-0.1) |
presence of Tβ10, n pts (%) | 13 (54.2%) | 15 (68.2%) |
Tβ10 (μmol/L, mean ± SD) | 0.059 ± 0.088 | 0.040 ± 0.049 |
(median, range) | (0.01, 0-0.3) | (0.02, 0-0.17) |
Tβ4/sTβ4 ratio (mean ± SD) | 7.328 ± 4.626 * | 14.582 ± 4.907 |